Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT05571059 · RECRUITING

Trial details

NCT number: NCT05571059
Sponsor: Cumberland Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2024-01-31
Primary completion: 2027-01-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.